🇺🇸 FDA
Patent

US 9795655

Modified MT-SP1 proteases that inhibit complement activation

granted A61KA61K38/482A61K38/49

Quick answer

US patent 9795655 (Modified MT-SP1 proteases that inhibit complement activation) held by Catalyst Biosciences, Inc. expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/482, A61K38/49, A61P, A61P1/00